PB2267 PERCEPTION OF THE DISCONTINUATION OF TYROSINE‐KINASE INHIBITOR TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA OF THE ANDALUSIAN GROUP OF CML (GALMC) | Publicación